A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s00520-016-3445-2
Published Online: 2016-10-13
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakagaki, Midori https://orcid.org/0000-0003-4086-6960
Barras, Michael
Curley, Cameron
Butler, Jason P.
Kennedy, Glen A.
Funding for this research was provided by:
Royal Brisbane and Women’s Hospital Foundation
License valid from 2016-10-13